Abstract
Cardiovascular events are frequently reported in patients with acromegaly and they are usually related to arterial hypertension. Aim of the present study was to assess the 24-hour profile of blood pressure (BP) and heart rate (HR) in patients with active acromegaly and to correlate them with clinical and hormonal data. Sixteen patients and 16 healthy, age and sex matched subjects underwent ambulatory blood pressure monitoring by means of a portable automatic device (SpaceLabs monitor 90207, Kontron) with measurements every 20 minutes for 24 hours. The presence of the nocturnal fall was assessed by the calculation of the night-day systolic and diastolic ratio. The mean 24-hour diastolic BP was significantly higher in acromegalic patients than in controls (79.1±11.5 mmHg vs 70.8±5.3 mmHg, p<0.05) and the circadian diastolic profile was flatten. In fact, 10/16 patients were defined as nondippers while this figure was 2/16 in the control group (62% vs 12%, p<0.01). Also the mean 24-hour systolic BP was higher in acromegalic patients than in controls (124.8±17.2 mmHg vs 114.1±8.6 mmHg, p<0.05). The circadian systolic profile paralleled that of diastolic and was flatten, without a significant nocturnal fall. Ten out of 16 patients were nondippers compared to 2/16 controls (62 vs 12%, p<0.01). No significant correlation was found between mean 24-hour BP, either diastolic or systolic, and demographic or hormonal characteristics of the patients. HR patterns did not differ between patients and controls and were characterized by a prominent nocturnal fall.
Similar content being viewed by others
References
Balzer R., Mc Cullagh E.P. Hypertension in acromegaly. Am. J. Med. Sci. 37: 449, 1959.
Molitch M.E. Clinical manifestations of acromegaly. Endocrin. Metab. Clin. North Am. 23: 597, 1992.
Pepine C.J., Aloia J. Hearth muscle disease in acromegaly. Am. J. Med. 48: 530, 1970.
Wright A.D., Hill D.M., Lowy C., Froser T.R. Mortality in acromegaly. Q. J. Med. 39: 1, 1970.
Alexander L., Appleton D., Hall R., Ross W.H., Wilkinson R. Epidemiology of acromegaly in the Newcastle region. Clin. Endocrinol. (Oxf.) 12: 71, 1980.
Bengtsson B.A., Eden S., Ernest I., Oden A, Sjogren B. Epidemiology and long term survival in acromegaly. Acta Med. Scandinava 223: 327, 1988.
Bates A.S., Van’t Hoff W., Jones J. M., Clayton R.N. The effect of treatment on life expectancy in acromegaly. In: Wass J.A.M. (Ed.), Treating acromegaly. J. Endocrinol. Ltd, Bristol, 1994, p. 175.
Biglieri E., Watlington C.O., Forsham P.H. Sodium retention with human growth hormone and its subfractions. J. Clin. Endocrinol. Metab. 21: 361, 1961.
Cain J.P., Williams G.H., Dluhy R.G. Plasma renin activity and aldosterone secretion in patients with acromegaly. J. Endocrinol. Invest. 34: 73, 1972.
Cuneo R.C., Salomon F., Wilmshurst P., Byrue C., Wiles C.M., Hesp R., Sonksen P.M. Cardiovascular effects of growth hormone treatment in growth-hormone deficient adults: stimulation of the renin-aldosterone system. Clin. Sci. 81: 587, 1991.
Haak T., Schirmer U., Scheuermann E. Haemodynamic and renal responsiveness to human atrial natriuretic peptide (hANF) in active acromegaly. In: Mantero F., Takeda R., Scoggins B.A., Biglieri E.G., FUnder J.W. (Eds.), The adrenal and hypertension: Raven Press, New York, 1989, vol. 57, p. 391.
Deray G., Rieu M., Devynck M.A. et al. Evidence of an endogenous digitalis-like factor in the plasma of patients with acromegaly. N. Engl. J. Med. 316: 575, 1987.
Imai Y., Abe K., Sasaky S., Minai N., Nihei M., Murakata M., Murakoni O, Matsue K., Sekino H., Miura Y., Yoshinaga K. Altered circadian blood pressure rhythm in patients with Cushing’s Syndrome. Hypertension. 12: 11, 1988.
Piovesan A., Panarelli M., Terzolo M., Osella G., Matrella C., Paccotti P., Angeli A. 24-hour profiles of blood pressure and hearth rate in Cushing’s syndrome: relationship between cortisol and cardiovascular rhythmicities. Chronobiol. Int. 7: 263, 1990.
Statius van Eps R.G., Van den Meiracker A.H., Boomsma F. et al. Diurnal variation of blood pressure in patients with catecolamine-producing tumors. Am. J. Hypertens. 7: 492, 1994.
Meisel S.R., Mor-Avi V., Rosenthal T., Akselrod S. Spectral analysis of systolic blood pressure signal in secondary hypertension: a method for the identification of phaechromocytoma. J. Hypertens. 12: 269, 1994.
Veglio F., Pinna G., Melchio R., Rabbia F., Molino P., Torchio C., Chiandussi L. Twenty-four hour power spectral analysis by Maximum Entropy Method of blood pressure in primary hyperaldosteronism. Blood pressure. 2: 189, 1993.
White W.B., Malchoff C. Diurnal blood pressure variability in mineralocorti-coid excess syndrome. Am. J. Hypertens. 5: 414, 1992.
Fallo F., Barzon L., Casiglia E., Boscaro M., Sonino N. Effect of octreotide on 24-hour blood pressure in acromegaly. 79th Annual Meeting of the endocrine Society. June 11, 1997.
Coca A. Circadian rhythm and blood pressure control: physiological and pathophysiological factors. J. Hypertens. 12 (Suppl. 5): S13, 1994.
Parati G., Ravogli A., Frattola A., Groppelli A., Ulian L., Santucci C., Mancia G. Blood pressure variability:clinical implications and effects of antihypertensive treatment. J. Hypertens. 12 (Suppl. 5): S35, 1994.
O’Brien E., Sheridan J., O’Malley K. Dippers and non-dippers. Lancet. ii: 397, 1988.
Shimada K., Kawamoto A., Matsubayashi K., Nishinaga A., Kimura S., Ozawa T. Diurnal blood pressure variations and silent cere-brovascular damage in elderly patients with hypertension. J. Hypertens. 10: 875, 1992.
Palatini P., Penzo M., Raccioppa A., Zugno E., Guzzardi G., Anaclerio M., Pessina A.C. Clinical relevance of nighttime blood pressure and daytime blood pressure variabiIity. Arch. Intern. Med. 152: 1855, 1992.
O’Brien E., Sheridan J., Browne E. et al. Validation of the SpaceLabs 90202 ambulatory blood pressure recorder. J. Hypertens. 7 (Suppl. 6): S388, 1989.
Staessen J., Bulpitt C.J., O’Brien E., Cox J., Fargard R., Stanton A. The diurnal blood pressure profile. A population study. Am. J. Hypertens. 5: 386, 1992.
Staessen J., Fargard R., Lijnen P.J., et al. The mean and range of the ambulatory blood pressure in normotensive subjects from a meta-analysis of 23 studies. Am. J. Cardiol. 67: 723, 1991.
Ritche C.M., Atkinson A.B., Kennedy A.L. et al. Ascertainment and natural history of trated acromegaly in Northern Ireland. Ulster Med. J. 59: 52, 1990.
Hamwi G.J., Skillman T.G., Tufts K.C.J. Acromegaly. Am. J. Med. 29: 690, 1960.
Jonas E.A., Aloia J.F., Lane F.J. Evidence of subclinical heart muscle dysfunction in acromegaly. Chest 67: 190, 1975.
Martins J.B., Keber R.E., Sherman B.M., Mercus M.L., Ehrardt J.C. Cardiac size and function in acromegaly. Circulation 56: 865, 1977.
Bruel A., Oxlund H. Biosynthetic growth hormone increases the collagen deposition rate in rat aorta and heart. Eur. J. Endocrinol. 132: 195, 1995.
Grant M.B., Wargovich T.J., Ellis E.A. et al. Localization of insulin-like growth factor I and inhibition of coronary smooth muscle cell growth by somatostatin analogues in human coronary smooth muscle cells. A potential treatment for restenosis? Circulation 89: 1511, 1994.
Khorsandi M., Fagin J.A., Fishbein M.C. et al. Effects of hypophisectomy on vascular insulin-like growth factor I gene expression after ballon denudation in rats. Atherosclerosis 93: 115, 1992.
Sarzani R., Paci V.M., Lanari A. et al. Induction of cardiac growth factors and growth factor receptors gene expression by growth hormone in normotensive and hypertensive rats. High Blood Pressure 5: 139, 1996.
Davies A.B., Gould B. A., Cashman P.M.M. et al. Circadian rhythm of blood pressure in patients dependent on ventricular demand pace-makers. Br. Heart J. 52: 93, 1984.
Imai Y., Abe K., Munakata M., Sakuma H., Hashimoto J., Imai K., Sekino H., Yoshinaga K. Does ambulatory blood pressure monitoring improve the diagnosis of secondary hypertension? J. Hypertens. 8: S71, 1990.
Verdecchia P., Schillaci G., Boldrini F., Zampi I., Porcellati C. Variability between current definitions of normal ambulatory blood pressure. Hypertension 20: 555, 1992.
Schulte K. L., Liederwald K., Meyer-Sabellek W., Van Gemmeren D., Lenz T., Gotzen R. Relationships between ambulatory blood pressure, forearm vascular resistence and left ventricular mass in hypertensive and normotensive subjects. Am. J. Hypertens. 6: 786, 1993.
Lie J.T., Grossman S.J. Pathology of the heart in acromegaly: anatomic findings in 27 autopsied patients. Am. Heart J. 100: 41, 1980.
Fazio S., Cittadini A., Cuocolo A., Merola B., Sabatini O., Nicolai E., Biondi D, Lombardi G, Saccà L. Impaired cardiac performance is a distinct feature of uncomplicated acromegaly. J. Clin. Endocrinol. Metab. 79: 441, 1994.
Terzolo M., Avonto L., Matrella C., Pozzi R., Luceri S., Borretta G., Pecchio F., Ugliengo G., Magro G.P., Reimondo G., Uslenghi E., GrecoLucchina P., Angeli A. Doppler echocardiographic patterns in patients with acromegaly. J. Endocrinol. Invest. 18: 613, 1995.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Terzolo, M., Matrella, C., Boccuzzi, A. et al. Twenty-four hour profile of blood pressure in patients with acromegaly. Correlation with demographic, clinical and hormonal features. J Endocrinol Invest 22, 48–54 (1999). https://doi.org/10.1007/BF03345478
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF03345478